NVIDIA Corporation
NASDAQ: NVDA · TECHNOLOGY · SEMICONDUCTORS
Updated 2026-06-12
NVIDIA Corporation (NVDA) Stock Valuation Analysis
Fair value estimate, historical valuation range, and quality signals for NVDA.
Valued
Fundamentals support the current valuation. Strong combination of growth, quality, and price.
NVDA historical valuation range
Where current P/E sits in NVDA's own 5Y range.
NVDA intrinsic value (DCF)
DCF-based fair value estimate vs current market price.
Intrinsic value calculated using discounted cash flow (DCF) model based on projected free cash flows, discount rate, and terminal growth assumptions. A positive margin of safety indicates the current price is below estimated fair value, providing a cushion against estimation error.
NVDA valuation signals
Quick-read green flags, caution flags, and risks based on current metrics.
P/E Ratio — History
Current: 34.12x
P/S Ratio — History
Current: 21.29x
Is NVDA overvalued in 2026?
NVIDIA Corporation (NVDA) currently trades at $205.19 per share with a market capitalization of $5,396,923,154,000.00. Based on our multi-factor framework, the stock looks attractively valued with a Smart Value Score of 80/100. This score blends growth quality, financial health, and price attractiveness into a single institutional-grade read.
The stock trades at a P/E ratio of 34.1x, below its 5-year median of 38.5x. The PEG ratio of 0.69 suggests earnings growth is outpacing the multiple, a classic sign of undervaluation.
Looking at its own history, NVDA is currently trading cheaper than 98% of the last 5Y on P/E. This places it in the 2th percentile of its historical range, a level that has historically coincided with attractive entry points.
Our discounted cash flow model estimates NVDA's intrinsic value at $119.30 per share, against the current market price of $205.19. This implies a premium to fair value of -71.92%. The current price sits well above what projected cash flows justify, implying investors are paying for growth that has not yet materialized.
Financial quality is a concern. The Piotroski F-Score of 3/9 flags weakening fundamentals that deserve closer scrutiny before the valuation case can be fully trusted.
Bottom line: NVDA looks attractively valued on our framework, with a Smart Value Score of 80/100. The combination of reasonable price, healthy growth, and quality fundamentals makes it worth serious consideration.
Frequently asked questions
Is NVDA overvalued?
NVDA scores 80/100 on our Smart Value Score (Grade A), a strong overall profile. On valuation specifically, the DCF puts intrinsic value below the current price, so the stock is expensive on cash flow today. The score reflects growth and quality carrying it, not a cheap entry point.
What is NVDA's fair value?
Our DCF model estimates NVDA's intrinsic value at $119.30 per share, versus the current price of $205.19, a margin of safety of -71.92%. Fair value is the present value of the cash flows we project the business to produce, so a price above it means the market is paying up for growth the model does not yet assume.
What P/E ratio does NVDA trade at?
NVDA trades at a P/E of 34.1x on trailing twelve-month earnings, against a 5-year median of 38.5x. P/E is what you pay per dollar of profit, and sitting below its own median means the stock is cheaper than usual relative to its earnings.
Is NVDA a buy based on valuation?
Our Smart Value rating for NVDA is Strong Buy, from a Smart Value Score of 80/100 that blends growth, quality, and valuation. The rating leans on growth and financial strength, and valuation is usually the weakest leg for a name scoring this high. This is research to inform your decision, not personalized financial advice.
How does NVDA's valuation compare to its history?
On P/E, NVDA sits in the 2nd percentile of its own 5Y range, historically cheap relative to where it has traded. A low percentile means today's multiple is near the bottom of its historical band.
What is NVDA's Smart Value Score?
NVDA's Smart Value Score is 80/100. It is a proprietary WallStSmart metric blending growth quality, financial health, and valuation into a single 0-100 read, and scores above 75 are rare, signaling strong multi-factor alignment.